GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Sample GSM1358031 Query DataSets for GSM1358031
Status Public on Apr 01, 2015
Title HCT-116 parental (A)
Sample type SRA
Source name Colon cancer cell line
Organism Homo sapiens
Characteristics cell line: HCT-116 parental cell line is sensitive for both OxPt and SN38
Treatment protocol Oxaliplatin or SN-38 resistant cell lines were generated in our laboratory over a period of 8-10 months by continuous exposure to gradually increasing concentrations of drug. The cell lines were passaged three times at each drug concentration and cell vials were frozen at each increase in drug concentration. Prior to subsequent experiments, the cells were maintained in drug-free growth medium for at least 1 week.
Growth protocol The cell lines HCT116 and HT29 were obtained from the NCI/Development Therapeutics Program, while LoVo was obtained from the American Tissue Culture Collection. Cells were maintained at 37 ˚C, 5% CO2 in RPMI 1640+Glutamax growth medium (Invitrogen, Naerum, Denmark) supplemented with 10% foetal calf serum (Invitrogen).
Extracted molecule genomic DNA
Extraction protocol Genomic DNA was isolated from the cell lines and clinical samples using DNeasy® Blood & Tissue Kit (QIAGEN) following manufacturer's protocol. The extracted genomic DNA was verified by agarose gel electrophoresis, and the concentration was estimated by NanoDrop (Thermo Scientific). Furthermore, BioAnalyzer 2100 DNA Chip was used to ensure the quality, quantity and integrity for the genomic DNA.
Five µg genome DNA from the cell line models and the clinical samples was digested by restriction enzyme, MspI (New England BioLabs) over night at 37 °C and QIAGEN Mini Purification kit was used to purify the digested products. End repair, adding A and adaptors, where the cytosines in the paired end adaptor sequence were methylated, was performed. The ligated product was subjected to size selection in 2% agarose gel (Bio-RAD) at 100 V for 2 hours. Agarose gel bands with the inserted genomic DNA size 40 ~ 110 bp and the inserted genomic DNA size 110 ~ 220 bp were excised, so that two libraries were generated from the MOMA3, MOMA4, MOMA5, MOMA7, MOMA8 and MOMA9 (one consisting of 40 ~ 110 bp target sequences and the other of 110 ~ 220 bp target sequences). The rest clinical samples and all cell line samples were generated with a single library with inserted DNA fragments with 40-300 bp. The DNA from the excised gel pieces was recovered by QIAGEN Gel Extraction Purification Kit, followed by bisulfite treatment using ZYMO EZ DNA Methylation-Gold kit. The resulting converted DNA was amplified by PCR and purified. The RRBS libraries were performed paired-end 50 nt sequencing with HiSeq 2000 (Illumina).
Library strategy Bisulfite-Seq
Library source genomic
Library selection Reduced Representation
Instrument model Illumina HiSeq 2000
Description A
Data processing Illumina Casava1.7 software used for basecalling.
The adaptor sequences were filtered out from the subsequent analysis and the resulting reads were aligned using Bismark software. Only uniquely mapped reads, which had restriction enzyme cutting site at the 5’ end were used to subsequent methylation analysis.
The sequencing depth and the percentage of methylated cytosines/total investigated cytosines for each C location were calculated. The genomic annotation information was based on the hg19 human genome ( Differentially methylated cytosines were identified by QDMR.
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text file includes the significantly differented cytosines and the correpsonding methylation level (percentage) values for each sample in the colon cancer cell line models and the clinical samples.
Submission date Mar 27, 2014
Last update date May 15, 2019
Contact name Jian Li
Phone 45+40608651
Organization name Aarhus University
Department Institute of Biomedicine
Lab 10
Street address The Bartholin Building
City Aarhus
ZIP/Postal code DK-8000
Country Denmark
Platform ID GPL11154
Series (1)
GSE56269 The Potential Role of Alu Y in the Development of Resistance to SN38 (Irinotecan) or Oxaliplatin in Colorectal Cancer
BioSample SAMN02709076
SRA SRX501979

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap